243 related articles for article (PubMed ID: 16081512)
61. The DNA damage-binding protein XPC is a frequent target for inactivation in squamous cell carcinomas.
de Feraudy S; Ridd K; Richards LM; Kwok PY; Revet I; Oh D; Feeney L; Cleaver JE
Am J Pathol; 2010 Aug; 177(2):555-62. PubMed ID: 20616346
[TBL] [Abstract][Full Text] [Related]
62. Characterization of molecular defects in xeroderma pigmentosum group C.
Li L; Bales ES; Peterson CA; Legerski RJ
Nat Genet; 1993 Dec; 5(4):413-7. PubMed ID: 8298653
[TBL] [Abstract][Full Text] [Related]
63. The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts.
Emmert S; Kobayashi N; Khan SG; Kraemer KH
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2151-6. PubMed ID: 10681431
[TBL] [Abstract][Full Text] [Related]
64. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
[TBL] [Abstract][Full Text] [Related]
65. Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum.
Satokata I; Tanaka K; Yuba S; Okada Y
Mutat Res; 1992 Mar; 273(2):203-12. PubMed ID: 1372103
[TBL] [Abstract][Full Text] [Related]
66. Lack of XPC leads to a shift between respiratory complexes I and II but sensitizes cells to mitochondrial stress.
Mori MP; Costa RA; Soltys DT; Freire TS; Rossato FA; Amigo I; Kowaltowski AJ; Vercesi AE; de Souza-Pinto NC
Sci Rep; 2017 Mar; 7(1):155. PubMed ID: 28273955
[TBL] [Abstract][Full Text] [Related]
67. New functions of XPC in the protection of human skin cells from oxidative damage.
D'Errico M; Parlanti E; Teson M; de Jesus BM; Degan P; Calcagnile A; Jaruga P; Bjørås M; Crescenzi M; Pedrini AM; Egly JM; Zambruno G; Stefanini M; Dizdaroglu M; Dogliotti E
EMBO J; 2006 Sep; 25(18):4305-15. PubMed ID: 16957781
[TBL] [Abstract][Full Text] [Related]
68. Diagnosing xeroderma pigmentosum group C by immunohistochemistry.
de Feraudy S; Boubakour-Azzouz I; Fraitag S; Berneburg M; Chan L; Chew K; Clericuzio CL; Cunningham B; Tope WD; Cleaver JE
Am J Dermatopathol; 2010 Apr; 32(2):109-17. PubMed ID: 19915453
[TBL] [Abstract][Full Text] [Related]
69. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S
Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758
[TBL] [Abstract][Full Text] [Related]
70. Characterisation of novel mutations in Cockayne syndrome type A and xeroderma pigmentosum group C subjects.
Ridley AJ; Colley J; Wynford-Thomas D; Jones CJ
J Hum Genet; 2005; 50(3):151-154. PubMed ID: 15744458
[TBL] [Abstract][Full Text] [Related]
71. Retroviral-mediated correction of DNA repair defect in xeroderma pigmentosum cells is associated with recovery of catalase activity.
Quilliet X; Chevallier-Lagente O; Zeng L; Calvayrac R; Mezzina M; Sarasin A; Vuillaume M
Mutat Res; 1997 Dec; 385(3):235-42. PubMed ID: 9506892
[TBL] [Abstract][Full Text] [Related]
72. Synergistic interactions between XPC and p53 mutations in double-mutant mice: neural tube abnormalities and accelerated UV radiation-induced skin cancer.
Cheo DL; Meira LB; Hammer RE; Burns DK; Doughty AT; Friedberg EC
Curr Biol; 1996 Dec; 6(12):1691-4. PubMed ID: 8994835
[TBL] [Abstract][Full Text] [Related]
73. Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-/- mice.
Cheo DL; Burns DK; Meira LB; Houle JF; Friedberg EC
Cancer Res; 1999 Feb; 59(4):771-5. PubMed ID: 10029060
[TBL] [Abstract][Full Text] [Related]
74. Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease.
States JC; Myrand SP
Mutat Res; 1996 Aug; 363(3):171-7. PubMed ID: 8765158
[TBL] [Abstract][Full Text] [Related]
75. Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation.
Itoh T; Linn S; Kamide R; Tokushige H; Katori N; Hosaka Y; Yamaizumi M
J Invest Dermatol; 2000 Dec; 115(6):981-5. PubMed ID: 11121129
[TBL] [Abstract][Full Text] [Related]
76. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain.
Tanaka K; Miura N; Satokata I; Miyamoto I; Yoshida MC; Satoh Y; Kondo S; Yasui A; Okayama H; Okada Y
Nature; 1990 Nov; 348(6296):73-6. PubMed ID: 2234061
[TBL] [Abstract][Full Text] [Related]
77. Biochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein.
Bunick CG; Miller MR; Fuller BE; Fanning E; Chazin WJ
Biochemistry; 2006 Dec; 45(50):14965-79. PubMed ID: 17154534
[TBL] [Abstract][Full Text] [Related]
78. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
[TBL] [Abstract][Full Text] [Related]
79. Xeroderma pigmentosum in a Malaysian child with identification of a novel homozygous nonsense mutation in XPC c.2167C>T.
Albela H; Ngu LH; Leong KF
Int J Dermatol; 2022 Sep; 61(9):e324-e326. PubMed ID: 35235204
[No Abstract] [Full Text] [Related]
80. Reduced capacity to repair irradiated adenovirus in fibroblasts from xeroderma pigmentosum heterozygotes.
Rainbow AJ
Cancer Res; 1980 Nov; 40(11):3945-9. PubMed ID: 7471045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
